06140342 is referenced by 19 patents and cites 6 patents.

Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.

Title
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
Application Number
9/390731
Publication Number
6140342
Application Date
September 7, 1999
Publication Date
October 31, 2000
Inventor
Ronald T Wester
Ledyard
CT, US
Roger B Ruggeri
Waterford
CT, US
Michael R Makowski
Salem
CT, US
Steven W Goldstein
Noank
CT, US
Agent
A Dean Olson
Gregg C Benson
Peter C Richardson
Assignee
Pfizer
NY, US
IPC
C07D 215/42
C07D 215/58
A61K 31/4706
View Original Source